| Title : Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit - Hoilund-Carlsen_2024_Ageing.Res.Rev__102348 |
| Author(s) : Hoilund-Carlsen PF , Alavi A , Barrio JR , Castellani RJ , Costa T , Herrup K , Kepp KP , Neve RL , Perry G , Revheim ME , Robakis NK , Sensi SL , Vissel B |
| Ref : Ageing Res Rev , :102348 , 2024 |
| Abstract : |
| PubMedSearch : Hoilund-Carlsen_2024_Ageing.Res.Rev__102348 |
| PubMedID: 38830549 |